Patents Examined by Nadia A Mahmood
  • Patent number: 10779809
    Abstract: A method includes providing an indwelling tool having a magnetic body at the inside of a luminal organ by inserting the tool into a working channel inserted from a natural opening of a living body to the luminal organ, in a manner such that an axis along a length of the magnetic body is arranged substantially parallel to a length direction of the working channel; disposing the tool in a vicinity of a diseased part of the luminal organ; applying a magnetic field to the magnetic body by using a magnetic field generating device provided at the outside of the luminal organ, so as to attract the magnetic body and make a side face of the magnetic body along the axis thereof push against a tissue in the vicinity of the diseased part; and lifting a tissue around a position of the tool, which includes the diseased part, by applying a magnetic force to the magnetic body by using the magnetic field generating device.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: September 22, 2020
    Assignee: OLYMPUS CORPORATION
    Inventors: Takayuki Suzuki, Takeshi Ohdaira
  • Patent number: 10772531
    Abstract: Aspects of the present disclosure are directed to systems, apparatuses, and methods for detecting and correcting for magnetic field distortions within a magnetic field used for medical magnetic localization systems.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: September 15, 2020
    Assignee: St. Jude Medical International Holding S.รก r.l.
    Inventors: Eitan Oren, Alon Izmirli, Adam Fischbach, Charles B. Byrd, Eric Betzler, Scott Meyerson, Guy Hevel, Adrian Herscovici, Roie Shlomovitz, Shay Levi, Nir Ben Dor
  • Patent number: 10765869
    Abstract: An example method for controlling delivery of electrical stimulation therapy includes maintaining, by one or more processors of a medical device configured to deliver electrical stimulation to a patient, a counter tied to a clock used by the medical device to deliver the electrical stimulation to the patient; and obtaining, by the one or more processors, one or more representations of sensed electrical signals for the patient that are referenced to counts of the counter. In this example, the method also includes identifying, based on the one or more representations of the sensed electrical signals for the patient, a count of the counter at which stimulation is to be delivered to the patient; and delivering, by the medical device and to the patient, electrical stimulation based on the identified count of the counter.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: September 8, 2020
    Assignee: Medtronic, Inc.
    Inventors: David L. Carlson, Heather D. Orser, Dale G. Suilmann, Kenneth J. Gutzman, Gregory J. Loxtercamp
  • Patent number: 10758191
    Abstract: A graphical representation may be displayed including at least a plurality of transducer graphical elements, each transducer graphical element of the plurality of transducer graphical elements representative of a respective transducer of a plurality of transducers of a transducer-based device. A set of user input may be received including an instruction set to reposition a first transducer graphical element in a state in which the first transducer graphical element is located at a first location in the graphical representation and a second transducer graphical element is located at a second location in the graphical representation, the second location closer to a predetermined location in the graphical representation than the first location. In response to conclusion of receipt of the set of user input, the first transducer graphical element may be repositioned from the first location in the graphical representation to the predetermined location in the graphical representation.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: September 1, 2020
    Assignee: KARDIUM INC.
    Inventors: Saar Moisa, Michael Hermann Weber
  • Patent number: 10758737
    Abstract: A medical system for sensing and regulating cardiac activity of a patient may include a cardioverter that is configured to generate and deliver shocks to cardiac tissue and a leadless cardiac pacemaker (LCP) that is configured to sense cardiac activity and to communicate with the cardioverter. The cardioverter may be configured to detect a possible arrhythmia and, upon detecting the possible arrhythmia, may send a verification request to the LCP to help conform that the possible arrhythmia is occurring. The LCP, upon receiving the verification request from the cardioverter, may be configured to activate one or more of a plurality of sensors to attempt to help confirm that the possible arrhythmia is occurring.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: September 1, 2020
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Qi An, Pramodsingh Hirasingh Thakur, Jeffrey E. Stahmann, Yinghong Yu, Michael J. Kane
  • Patent number: 10751006
    Abstract: A graphical representation may be displayed including at least a plurality of transducer graphical elements, each transducer graphical element of the plurality of transducer graphical elements representative of a respective transducer of a plurality of transducers of a transducer-based device. A set of user input may be received including an instruction set to reposition a first transducer graphical element in a state in which the first transducer graphical element is located at a first location in the graphical representation and a second transducer graphical element is located at a second location in the graphical representation, the second location closer to a predetermined location in the graphical representation than the first location. In response to conclusion of receipt of the set of user input, the first transducer graphical element may be repositioned from the first location in the graphical representation to the predetermined location in the graphical representation.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: August 25, 2020
    Assignee: KARDIUM INC.
    Inventors: Saar Moisa, Michael Hermann Weber
  • Patent number: 10737104
    Abstract: In embodiments, a wearable medical system (WMS) for an ambulatory patient, which can be a wearable cardioverter defibrillator (WCD) system, analyzes the patient's ECG signal to generate a detection outcome. The WMS also has an ambulatory user interface that outputs a human-visible indication. A programming device, such as a PC, a tablet, etc., establishes a communication link with the WMS during an in-person session with the patient. The programming device may include a programming screen that reproduces the human-visible indication in real time. An advantage can be that the person programming the WMS need not strain to look also at the ambulatory user interface at the time they are looking at the programming device. Another advantage can be that the patient will recognize that he or she is better protected, and have their confidence in the WMS increased, and therefore better comply with wearing the WMS as required.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: August 11, 2020
    Assignee: West Affum Holdings Corp.
    Inventors: David Peter Finch, Zoie Engman, Steven E. Sjoquist, Angela M. Stewart, Pamela Breske, Jonathan Paul Niegowski, Laura Marie Gustavson
  • Patent number: 10737099
    Abstract: Systems, devices and methods are disclosed that include an antenna for an implantable medical device, the antenna including a passageway extending through the antenna windings of the antenna, the passageway providing a pathway for an electrical connector providing at least one electrical connection between a power source and electronic circuitry included within the implantable medical device.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: August 11, 2020
    Assignee: Medtronic, Inc.
    Inventors: James R. Wasson, Mark E. Henschel, Andrew J. Ries, Rachel M. Day, Kris A. Peterson
  • Patent number: 10729346
    Abstract: A computer implemented method and system for confirming a device documented arrhythmia in cardiac activity are provided. The method is under control of one or more processors configured with executable instructions. The method obtains a cardiac activity (CA) data set that includes CA signals for a series of cardiac events and includes device documented (DD) markers within the series of cardiac events. The device documented markers are indicative of atrial fibrillation (AF) detected by the ICM utilizing an on-board R-R interval irregularity (ORI) process to analyze the CA signals. The method applies a feature enhancement function to the CA signals to form modified CA signals with enhanced sinus features and analyzes the enhanced sinus features in the modified CA signals. The method utilized a confirmatory feature detection process to identify false AF detection by the ORI process. The method records a result of the analysis identifying false AF detection by the ORI process.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: August 4, 2020
    Assignee: Pacesetter, Inc.
    Inventors: Fujian Qu, Jong Gill, Neha Malhotra, Stuart Rosenberg, Gene A. Bornzin, Fady Dawoud
  • Patent number: 10729898
    Abstract: An apparatus comprises a cardiac signal sensing circuit configured for coupling electrically to a plurality of electrodes and to sense intrinsic cardiac activation at three or more locations within a subject's body using the electrodes; a stimulus circuit configured for coupling to the plurality of electrodes; a signal processing circuit electrically coupled to the cardiac signal sensing circuit and configured to determine a baseline intrinsic activation vector according to the sensed intrinsic cardiac activation; and a control circuit electrically coupled to the cardiac signal sensing circuit and stimulus circuit and configured to: initiate delivery of electrical pacing therapy using initial pacing parameters determined according to the baseline intrinsic activation vector; initiate sensing of a paced activation vector; and adjust one or more pacing therapy parameters according to the paced activation vector.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: August 4, 2020
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Allan Charles Shuros, Yinghong Yu, David J. Ternes, Michael J. Kane, William J. Linder
  • Patent number: 10722704
    Abstract: Methods for implanting a puke generator (PG) within a pectoral region of a chest of a patient and devices having the PG. The PG has a housing that includes a PG electrode. Methods also include implanting at least one lead having first and second electrode segments with the first electrode segment positioned along an anterior of the chest of the patient and the second electrode segment positioned along at least one of a posterior of the patient or a side of the patient. The first and second electrode segments are positioned subcutaneously at or below an apex of a heart of the patient, wherein the PG electrode and the first and second electrode segments are configured to provide electrical shocks for antiarrhythmic therapy.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: July 28, 2020
    Assignee: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Avi Fischer, Kyungmoo Ryu, Gabriel A. Mouchawar
  • Patent number: 10722184
    Abstract: A graphical representation may be displayed including at least a plurality of transducer graphical elements, each transducer graphical element of the plurality of transducer graphical elements representative of a respective transducer of a plurality of transducers of a transducer-based device. A set of user input may be received including an instruction set to reposition a first transducer graphical element in a state in which the first transducer graphical element is located at a first location in the graphical representation and a second transducer graphical element is located at a second location in the graphical representation, the second location closer to a predetermined location in the graphical representation than the first location. In response to conclusion of receipt of the set of user input, the first transducer graphical element may be repositioned from the first location in the graphical representation to the predetermined location in the graphical representation.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: July 28, 2020
    Assignee: KARDIUM INC.
    Inventors: Saar Moisa, Michael Hermann Weber
  • Patent number: 10722629
    Abstract: A device for providing resuscitation or suspended state through redistribution of cardiac output to increase supply to the brain and heart for a patient. The device comprises an electrically controllable redistribution component in the form of a catheter, attachable to the patient and configured to interact with the patient to provide redistribution of the cardiac output to increase supply to the brain and heart, the redistribution component following a predefined reaction pattern based on an electrical signal, and computer configured to: receive a patient data which identifies physiological and/or anatomical characteristics of the patient; and provide the electrical signal for the redistribution component based on the patient data or a standard response. The device also comprises means for detection of blood vessels and motorized means for introduction of the catheter into an artery.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: July 28, 2020
    Assignee: Neurescue Aps
    Inventor: Habib Frost
  • Patent number: 10722715
    Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: July 28, 2020
    Assignee: SPR Therapeutics, Inc.
    Inventors: Maria E. Bennett, Joseph W. Boggs, Warren M. Grill, John Chae
  • Patent number: 10716940
    Abstract: An implant unit configured for implantation into a body of a subject is provided. The implant unit may include an antenna configured to receive a signal, and at least one pair of modulation electrodes configured to be implanted into the body of the subject in the vicinity of at least one nerve to be modulated. The at least one nerve may have a diameter less than about 2 millimeters at a modulation location, and the at least one pair of modulation electrodes may be configured to receive an applied electric signal in response to the signal received by the antenna and generate an electrical field to modulate the at least one nerve from a position spaced apart from the at least one nerve.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: July 21, 2020
    Assignee: Nyxoah SA
    Inventor: Adi Mashiach
  • Patent number: 10702210
    Abstract: A meal intake detection device includes: a memory; and a processor coupled to the memory and configured to: detect a rise of heart rate; extract as a meal intake candidate a time range from a detected rise to time when the heart rate decreases to a predetermined value in temporal changes in heart rate, and when a second meal intake candidate is extracted in a time range of an extracted first meal intake candidate, separate the first meal intake candidate and the second meal intake candidate along a predetermined line; and detect whether each of the first meal intake candidate and the second meal intake candidate is a meal intake based on feature quantities relating to the first meal intake candidate and the second meal intake candidate that are separated.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: July 7, 2020
    Assignee: FUJITSU LIMITED
    Inventors: Tatsuya Mori, Kazuho Maeda, Akihiro Inomata
  • Patent number: 10702695
    Abstract: The system includes various embodiments of components, including (1) a sensor array, (2) a processor, (3) a transmitter, (4) a receiver-stimulator, and (5) an implantable electrode array. The gustatory implant system generates tastant fingerprints by detecting tastants with an array of chemical sensors and then transmitting variable spatiotemporal stimulation patterns for an electrode array with electrode stimulating points positioned at different locations in the gustatory cortex (e.g., stimulating the chorda tympanic nerve). Different patterns of activity in the gustatory cortex are thereby generated which mimic the sense of taste in a subject. Once trained the system should be usable by a subject to detect or correctly identify or perceive one or more tastes. The system may also include an external electronic device for processing and displaying information to monitor ingestion of various substances in a subject.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: July 7, 2020
    Assignee: Virginia Commonwealth University
    Inventors: Richard M. Costanzo, Woon-Hong Yeo
  • Patent number: 10702445
    Abstract: The present invention provides, among other things, apparatus and methods of use for treating a subject in need of assistance with breathing. In some embodiments the subject suffers from airflow obstruction. In some embodiments, the subject suffers from chronic obstructive pulmonary disease.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: July 7, 2020
    Assignee: Apellis Holdings, LLC
    Inventors: Cedric Francois, Angus McLachlan
  • Patent number: 10695569
    Abstract: Methods and apparatuses for stimulation of the vagus nerve to treat inflammation including adjusting the stimulation based on one or more metric sensitive to patient response. The one or more metrics may include heart rate variability, level of T regulatory cells, particularly memory T regulatory cells, temperature, etc. Stimulation may be provided through an implantable microstimulator.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: June 30, 2020
    Assignee: SetPoint Medical Corporation
    Inventors: Jacob A. Levine, Michael A. Faltys, Jesse M. Simon
  • Patent number: 10688305
    Abstract: Systems, apparatus, and methods for ablation therapy are described herein, with a processor for confirming pacing capture or detecting ectopic beats. An apparatus includes a processor for receiving cardiac signal data captured by a set of electrodes, extracting a sliding window of the cardiac signal data, identifying a peak frequency over a subrange of frequencies associated with the extracted sliding window, detecting ectopic activity based at least on a measure of the peak frequency over the subrange of frequencies, in response to detecting ectopic activity, sending an indication of ectopic activity to a signal generator configured to generate pulsed waveforms for cardiac ablation such that the signal generator is deactivated or switched off from generating the pulsed waveforms. An apparatus can further include a processor for confirming pacing capture of the set of pacing pulses based on cardiac signal data.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: June 23, 2020
    Assignee: Farapulse, Inc.
    Inventor: Raju Viswanathan